Contemporary Concepts in the Diagnosis of Oral Cancer and Precancer

Dental Clinics of North America

Volumn 55, Issue 1, 2011, Pages 63-88

  Natarajan, Easwar ^a   Eisenberg, Ellen ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Epithelial dysplasia; Leukoplakia; Oral cancer; Precancer; Squamous cell carcinoma

Indexed keywords

AGE DISTRIBUTION; CLASSIFICATION; DENTISTRY; ETHNOLOGY; HUMAN; METHODOLOGY; MOUTH DISEASE; MOUTH TUMOR; PATHOLOGY; PRECANCER; REVIEW; SEX RATIO; SQUAMOUS CELL CARCINOMA;

AGE DISTRIBUTION; CARCINOMA, SQUAMOUS CELL; DENTISTRY; DIAGNOSIS, ORAL; HUMANS; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; SEX DISTRIBUTION;

EID: 78649400944     PISSN: 00118532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cden.2010.08.006     Document Type: Review

References (68)

1. Horner M.J., Ries L.A.G., Krapcho M., et al. SEER Cancer Statistics Review, 1975-2006. National Cancer Institute, Bethesda (MD) Available at:, Accessed January, 2010. http://seer.cancer.gov/csr/1975_2006.
2. Moore S.R., Johnson N.W., Pierce A.M., et al. The epidemiology of tongue cancer: a review of global incidence. Oral Dis 2000, 6(2):75-84.
3. Moore S.R., Johnson N.W., Pierce A.M., et al. The epidemiology of mouth cancer: a review of global incidence. Oral Dis 2000, 6(2):65-74.
4. Bishop J.M. Molecular themes in oncogenesis. Cell 1991, 64(2):235-248.
5. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100(1):57-70.
6. Funk G.F., Karnell L.H., Robinson R.A., et al. Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck 2002, 24(2):165-180.
7. Canto M.T., Devesa S.S. Oral cavity and pharynx cancer incidence rates in the United States, 1975-1998. Oral Oncol 2002, 38(6):610-617.
8. Mashberg A., Meyers H. Anatomical site and size of 222 early asymptomatic oral squamous cell carcinomas: a continuing prospective study of oral cancer. II. Cancer 1976, 37:2149-2157.
9. Moore C., Catlin D. Anatomic origins and locations of oral cancer. Am J Surg 1967, 114:510-513.
10. Scully C., Bedi R. Ethnicity and oral cancer. Lancet Oncol 2000, 1:37-42.
11. Rao D.N., Ganesh B., Rao R.S., et al. Risk assessment of tobacco, alcohol and diet in oral cancer-a case control study. Int J Cancer 1994, 58:469-473.
12. Merchant A., Husain S.S.M., Hosain M., et al. Paan without tobacco: an independent risk factor for oral cancer. Int J Cancer 2000, 86:128-131.
13. Brandwein-Gensler M., Hille J.J. Behind the cover: the gutkha story. Arch Otolaryngol Head Neck Surg 2003, 129:699-700.
14. Lingen M. Head and neck. Robbins and Cotran pathologic basis of disease, professional edition 2009, 744-749. Saunders, Elsevier, Philadelphia. 8th edition. V. Kumar, A.K. Abbas, N. Fausto (Eds.).
15. Califano J., van der Riet P., Westra W., et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996, 56:2488-2492.
16. Lippman S.M., Hong W.K. Molecular markers of the risk of oral cancer. N Engl J Med 2001, 344:1323-1326.
17. Blot W.J., McLaughlin J.K., Winn D.M., et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988, 48:3282-3287.
18. Wynder E.L., Bross I.J., Feldman R.M. A study of the etiological factors in cancer of the mouth. Cancer 1957, 10:1300-1323.
19. Hammond E.C., Horn D. Smoking and death rates - report on forty-four months of follow-up of 187,783 men. JAMA 1958, 166:1294-1308.
20. Morse D.E., Katz R.V., Pendrys D.G., et al. Smoking and drinking in relation to oral epithelial dysplasia. Cancer Epidemiol Biomarkers Prev 1996, 5(10):769-777.
21. Brunnemann K.D., Prokopczyk B., Djordjevic M.V., et al. Formation and analysis of tobacco-specific N-nitrosamines. Crit Rev Toxicol 1996, 26:121-137.
22. Hoffman D., Hoffman I. The changing cigarette, 1950-1995. J Toxicol Environ Health 1997, 50:307-364.
23. Scully C., Bagan J.V. Oral squamous cell carcinoma: overview of current understanding of etiopathogenesis and clinical implications. Oral Dis 2009, 15:388-399.
24. Schecht N.F., Franco E.L., Pintos J., et al. Effect of smoking cessation and tobacco type on the risk of cancers of the upper aerodigestive tract in Brazil. Epidemiology 1999, 10:412-418.
25. Baker F., Ainsworth S.R., Dye J.T., et al. Health risks associated with cigar smoking. JAMA 2000, 284:735-740.
26. Shimkada R., Peabody J.W. Tobacco control in India. Bull World Health Organ 2003, 81:48-52.
27. Schildt E.B., Eriksson M., Hardell I., et al. Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case-control study. Int J Cancer 1998, 77:341-346.
28. Lewin F., Norell S.E., Johansson H., et al. Smoking tobacco, oral snuff and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer 1998, 82:1367-1375.
29. Marwick C. Increasing use of chewing tobacco, especially among younger persons, alarms surgeon general. JAMA 1993, 269:195.
30. Winn D.M., Blot W.J., Shy C.M., et al. Snuff dipping and oral cancer among women in the southern United States. N Engl J Med 1981, 304:745-749.
31. Idris A.M., Ibrahim S.O., Vasstrand E.N., et al. The Swedish snus and the Sudanese toombak: are they different?. Oral Oncol 1998, 34:558-566.
32. Mashberg A., Garfinkel L., Harris S. Alcohol as a primary risk factor in oral squamous cell carcinoma. CA Cancer J Clin 1981, 31:146-155.
33. Franceschi S., Levi F., La Vecchia C., et al. Comparison of the effect of smoking and alcohol drinking between oral and pharyngeal cancer. Int J Cancer 1999, 83:1-4.
34. Hashibe M., Brennan P., Benhamou S., et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Consortium. J Natl Cancer Inst 2007, 99(10):777-789.
35. Campisi G., Giovannelli L. Controversies surrounding human papilloma virus infection, head & neck vs oral cancer, implications for prophylaxis and treatment. Head Neck Oncol 2009, 1(1):1-8.
36. Gillison M.L., Koch W.M., Capone R.B., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000, 92:709-720.
37. Syrjanen S. HPV infections and tonsillar carcinoma. J Clin Pathol 2004, 57:449-455.
38. Maitland N.J., Cox M.F., Lynas C., et al. Detection of human papillomavirus DNA in biopsies of human oral tissue. Br J Cancer 1987, 56:245-250.
39. Koch W.M., Lango M., Sewell D., et al. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope 1999, 109:1544-1551.
40. Lingen M.W., Chang K.W., McMurray S.J., et al. Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exon 5-9. Head Neck 2000, 22:328-335.
41. Sturgis E.M., Wei Q. Genetic susceptibility - molecular epidemiology of head and neck cancer. Curr Opin Oncol 2002, 14:310-317.
42. Tharp M.E., Shidnia H. Radiotherapy of verrucous carcinoma of the head and neck. Laryngoscope 1995, 105:391-396.
43. Jyothirmayi R., Sankaranarayanan R., Varghese C., et al. Radiotherapy in the treatment of verrucous carcinoma of the oral cavity. Oral Oncol 1997, 33(2):124-128.
44. Huang S.H., Lockwood G., Irish J., et al. Truths and myths about radiotherapy for verrucous carcinoma of larynx. Int J Radiat Oncol Biol Phys 2009, 73(4):1110-1115.
45. Lippman S.M., Hong W.K. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 1989, 17(3):691-694.
46. Chi A.C. Epithelial pathology. Oral and maxillofacial pathology 2009, 422-423. Saunders Elsevier, St. Louis (MO). 3rd edition. B.W. Neville, D.D. Damm, C.M. Allen, J.E. Bouquot (Eds.).
47. Slaughter D.P., Southwick H.W., Smejkal W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953, 6:963-968.
48. Axell T., Pindborg J.J., Smith C.J., et al. Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden May 18-21 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med 1996, 25:49-54.
49. "Leukoplakia", "keratosis", and intraepithelial squamous cell carcinoma of the head and neck. Tumors of the head and neck: clinical and pathological considerations 1974, 121-129. Williams & Wilkins, Baltimore (MD). J.G. Batsakis (Ed.).
50. Pindborg J.J. Oral cancer and precancer 1980, John Wright, Bristol (UK).
51. Crissman J.D. Upper aerodigestive tract. Pathology of incipient neoplasia 1993, vol. 28:44-63. WB Saunders, Philadelphia. 2nd edition. D.E. Henson, J. Albores-Saavedra (Eds.).
52. Hansen L.S., Olson J.A., Silverman S.J.R. Proliferative verrucous leukoplakia. A long-term study of thirty patients. Oral Surg Oral Med Oral Pathol 1985, 60(3):285-298.
53. Morton T.H., Cabay R.J., Epstein J.B. Proliferative verrucous leukoplakia and its progression to oral carcinoma: report of three cases. J Oral Pathol Med 2007, 36(5):315-318.
54. Bagan J.V., Jimenez Y., Sanchis J.M., et al. Proliferative verrucous leukoplakia: high incidence of gingival squamous cell carcinoma. J Oral Pathol Med 2003, 32(7):379-382.
55. Cabay R.J., Morton T.H., Epstein J.B. Proliferative verrucous leukoplakia and its progression to oral carcinoma: a review of the literature. J Oral Pathol Med 2007, 36(5):255-261.
56. Campisi G., Giovannelli L., Ammatuna P., et al. Proliferative verrucous vs. conventional leukoplakia: no significantly increased risk of HPV infection. Oral Oncol 2004, 40(8):835-840.
57. Bagan J.V., Jimenez Y., Murillo J., et al. Lack of association between proliferative verrucous leukoplakia and human papilloma virus infection. J Oral Maxillofac Surg 2007, 65(1):46-49.
58. Krutchkoff D.J., Eisenberg E., Anderson C. Dysplasia of oral mucosa: a unified approach to proper evaluation. Mod Pathol 1991, 4:113-119.
59. Thomson P.J. Field change and oral cancer: new evidence for widespread carcinogenesis?. Int J Oral Maxillofac Surg 2002, 31(3):262-266.
60. Sciubba J.J. Improving detection of precancerous and cancerous oral lesions. Computer assisted analysis of the oral brush biopsy. U.S. Collaborative Oral CDx Study Group. J Am Dent Assoc 1999, 130:1445-1457.
61. Lingen M.W., Kalmar J.R., Karrison T., et al. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol 2008, 44:10-22.
62. Svirsky J.A., Burns J.C., Carpenter W.M., et al. Comparison of computer-assisted brush biopsy results with follow-up scalpel biopsy and histology. Gen Dent 2002, 50:500-503.
63. Sceifele C., Schmidt-Westhausen A.M., Dietrich T., et al. The sensitivity and specificity of the Oral CDx technique: evaluation of 103 cases. Oral Oncol 2004, 40:824-828.
64. Poate T.W., Buchanan J.A., Hodgson T.A., et al. An audit of the efficacy of oral brush biopsy technique in a specialist Oral Medicine unit. Oral Oncol 2004, 40:829-834.
65. Patton L.L., Epstein J.B., Kerr A.R. Adjunctive techniques for oral cancer examination and lesion diagnosis. A systematic review of the literature. J Am Dent Assoc 2008, 139:896-905.
66. Gray M.G.L., Burls A., Elley K. The clinical effectiveness of toluidine blue dye as an adjunct to oral cancer screening in general dental practice. A West Midlands Development and Evaluation Service Report Available at:, Accessed January, 2010. http://www.pcpoh.bham.ac.uk/publichealth/wmhtac/pdf/toluidine_blue.pdf.
67. Huber M.A., Bsoul S.A., Terezhalmy G.T. Acetic acid wash and chemiluminescent illumination as an adjunct to conventional oral soft tissue examination for the detection of dysplasia: a pilot study. Quintessence Int 2004, 35:378-384.
68. Poh C.F., Zhang L., Anderson D.W., et al. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res 2006, 12(22):6716-6722.